XML 45 R32.htm IDEA: XBRL DOCUMENT v3.22.1
REVENUE
12 Months Ended
Dec. 31, 2021
REVENUE  
REVENUE

24.   REVENUE

Revenue consists of ASC 606 and ASC 842 revenue. The Group's revenues , net of value-added tax, disaggregated by revenue source are as follows:

For the Years Ended December 31,

2019

2020

2021

2021

RMB

RMB

RMB

US$

ASC 606 revenue:

    

  

    

  

    

  

    

  

Management and technical support

 

48,416

 

36,948

 

64,599

10,137

Brand royalty fees

 

5,081

 

 

 

Medical solution

 

9,482

 

26,105

 

217,375

 

34,110

Medical service

 

54,048

 

76,997

 

101,854

15,983

Medicine income

 

22,777

 

30,055

 

59,321

9,309

ASC 606 revenue

 

139,804

 

170,105

 

443,149

69,539

ASC 842 revenue:

 

 

 

 

Operating lease income*

 

53,485

 

45,847

 

35,913

5,635

Sales-type lease income*

 

1,130

 

4,130

 

5,210

818

Direct financing lease income*

 

3,944

 

2,929

 

1,361

 

214

ASC 842 revenue

 

58,559

 

52,906

 

42,484

6,667

Total revenue

198,363

223,011

485,633

76,206

*     Operating lease income, sales-type lease income and direct financing lease income were recognized under ASC 842, Leases.